Alexander B Olawaiye, Md

This study is testing a new three-drug combination for women with recurrent ovarian cancer that has stopped responding to platinum-based chemotherapy. The goal is to see if adding an experimental drug called ALX148 to two existing treatments (liposomal doxorubicin and pembrolizum…